| Useful Advices |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Sales Teleselling > Why Don't Telemarketers Earn More? |
|
Useful Advices - Why Don't Telemarketers Earn More?
I used to literally sit at my father’s feet while he made business to business calls, to introduce himself, and to s According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product et appointments. He was a spectacular telemarketer, before that word was invented. His formal title varied, but on ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in e of them was, Account Executive. Wherever he worked, he rose to the top in sales, and his earnings reflected his ac lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. hievements. He used to enjoy the fact that his ministrations were largely invisible to his cohorts, and he made a p here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe oint to make his calls from home, to keep them shrouded in mystery. His peers and managers saw sales results, but th d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ey seldom saw sales processes. I think if he were alive today he’d agree that the most crucial part of his success ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc came from telephone effectiveness. Without breaking the ice and being able to get through to top decision makers and easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi setting appointments with them, there would have been significantly fewer sales. Today, my dad might have had peop nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically le making calls for him, and he would have rewarded them, handsomely. They are doing the heavy lifting of the persu and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ asive process, opening doors and making a smooth entry. Why shouldn’t they earn top dollar? There are some biases t ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi hat hold down their wages, unfairly, I believe. Favoritism is shown toward field salespeople, who almost universally ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a earn more in a company that has both inside and outside sellers. But as most astute observers can attest, it is ea dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod sier to transform an inside person into a field person, than doing the opposite. What does this say about their resp cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ective skills? To me, it says you have to be more talented, more resourceful if you’re on the phone. If so, why are tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen n’t you paid at least the same, if not more than the outside person? Perhaps field selling is thought to be more ar t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel duous because it involves driving a car, occasionally in traffic? If you’re inside, you don’t have to brave the elem ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ents? You’re closer to a coffee machine? No matter how you slice it, it’s very hard to generate a sensible and defe y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products nsible reason that telemarketers are paid less money. If you have a viable explanation, please send it my way! Unti . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de l telemarketers are recognized and rewarded for their true and significant contributions, we’ll continue to have dif elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ficulty staffing the phones with talented, motivated folks who stick around and see it as a solid career opportunity tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Why Don't We Go For Self-Employment? Reasons To Exhibit: How Small Or Medium Sized Businesses Can Benefit From Exhibitions
|